ClinConnect ClinConnect Logo
Search / Trial NCT07055971

Pain Neuroscience Education, Conditioned Pain Modulation and Emotional Processes in Fibromyalgia

Launched by UNIVERSIDAD DE GRANADA · Jun 27, 2025

Trial Information

Current as of July 22, 2025

Enrolling by invitation

Keywords

Fibromyalgia Chronic Pain Health Education Pain Neuroscience Education Emotional Intellegence Condioned Pain Modulation Central Sensitization

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of Fibromyalgia in accordance with the American College of Rheumatology criteria for classifying Fibromyalgia (2016 revision) by a rheumatologist of the Public Health System of Andalusia (Spain)
  • Exclusion Criteria:
  • Presence of liver, cardiac, or renal disease.
  • Presence of previous inflammatory rheumatic disease or neurological disorders.
  • Presence of infectious processes, fever, hypotension, or respiratory alterations.
  • Severe physical disability or severe psychiatric illness.
  • Previous surgical intervention prior to the study period.
  • Presence of associated comorbidities (chemical hypersensitivity syndrome, chronic fatigue syndrome, interstitial cystitis, etc.).
  • Receiving any other non-pharmacological therapy.

About Universidad De Granada

The Universidad de Granada is a prestigious academic institution in Spain, renowned for its commitment to research and innovation in the medical and health sciences. With a strong emphasis on interdisciplinary collaboration, the university engages in a wide range of clinical trials designed to advance medical knowledge and improve patient care. Its dedicated team of researchers and clinicians work closely to ensure the ethical conduct and scientific rigor of all trials, contributing to the advancement of evidence-based medicine. The Universidad de Granada is dedicated to fostering an environment that promotes excellence in research, ultimately aiming to translate findings into clinical practice for the benefit of society.

Locations

Granada, Andalusia, Spain

Patients applied

0 patients applied

Trial Officials

Antonio Casas Barragán, PhD

Principal Investigator

Universidad de Granada

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported